Serum Activin A is not associated with carcinoid heart disease (CHD) in patients with neuroendocrine tumors (NET)

被引：0
|
作者：
Levy, S. [1 ]
Kilgallen, A. B. [2 ]
Korse, C. M. [1 ]
Oerlemans, M. J. F. [2 ]
Sluijter, J. P. G. [2 ]
Valk, G. D. [2 ]
van Laake, L. W. [2 ]
Tesselaar, M. E. T. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2022年 / 34卷
关键词：
chd; carcinoid heart disease; biomarker; nt-probnp; activin a;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F12
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [41] Carcinoid heart disease associated with primary ovarian carcinoid tumor
    Chaowalit, N
    Connolly, HM
    Schaff, HV
    Webb, MJ
    Pellikka, PA
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (10): : 1314 - 1315
  • [42] Health resource utilisation by patients with neuroendocrine tumours with or without carcinoid heart disease: a multinational study
    Tanaka, Hugo
    Uema, Deise
    Rego, Juliana F. M.
    Weschenfelder, Rui F.
    D'Agustini, Nathalia
    Rocha Filho, Duilio R.
    O'Connor, Juan M.
    Luca, Romina
    Nunez, Jose Eduardo R.
    de Barros e Silva, Jose
    Riechelmann, Rachel P.
    ECANCERMEDICALSCIENCE, 2020, 14
  • [43] Protocol for the Examination of Specimens From Patients With Neuroendocrine Tumors (Carcinoid Tumors) of the Colon and Rectum
    Washington, Mary Kay
    Tang, Laura H.
    Berlin, Jordan
    Branton, Philip A.
    Burgart, Lawrence J.
    Carter, David K.
    Compton, Carolyn C.
    Fitzgibbons, Patrick L.
    Frankel, Wendy L.
    Jessup, J. Milburn
    Kakar, Sanjay
    Minsky, Bruce
    Nakhleh, Raouf E.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (02) : 176 - 180
  • [44] A unique heart disease associated with a unique cancer: Carcinoid heart disease
    Roberts, WC
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02): : 251 - 256
  • [45] Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour
    Simoes-Pereira, Joana
    Wang, Lai Mun
    Kardos, Attila
    Grossman, Ashley
    ACTA MEDICA PORTUGUESA, 2017, 30 (05): : 421 - 425
  • [46] Phase II Trial of Cabozantinib in Patients with Carcinoid and Pancreatic Neuroendocrine Tumors
    Chan, J.
    Faris, J.
    Murphy, J.
    Blaszkowsky, L.
    McCleary, N.
    Meyerhardt, J.
    Abrams, T.
    Zhang, S.
    Reardon, A.
    Fitzpatrick, B.
    Kulke, M.
    Ryan, D.
    NEUROENDOCRINOLOGY, 2018, 106 : 213 - 213
  • [47] Phase II Trial of Cabozantinib in Patients With Carcinoid and Pancreatic Neuroendocrine Tumors
    Chan, Jennifer
    Faris, Jason
    Murphy, Janet
    Blaszkowsky, Lawrence
    Kwak, Eunice
    McCleary, Nadine
    Fuchs, Charles
    Meyerhardt, Jeffrey
    Ng, Kimmie
    Zhu, Andrew
    Abrams, Thomas
    Wolpin, Brian
    Zhang, Sui
    Reardon, Amanda
    Fitzpatrick, Bridget
    Kulke, Matthew
    Ryan, David
    PANCREAS, 2018, 47 (03) : 334 - 334
  • [48] Factors associated with progression of carcinoid heart disease
    Moller, JE
    Connolly, HM
    Rubin, J
    Seward, JB
    Modesto, K
    Pellikka, PA
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11): : 1005 - 1015
  • [49] Interest of serum and urinary 5HIAA, serotonin, chromogranin A and NT-proBNP assays as predictive factors for the development of carcinoid heart disease in neuroendocrine tumors
    Lecoeur, A.
    Sfeir, R. M.
    Damour, J.
    Lombard-Bohas, C.
    Gerard, L.
    Francois, L.
    Forestier, J.
    Walter, T.
    Chardon, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 162 - 162
  • [50] VONRECKLINGHAUSENS DISEASE ASSOCIATED WITH GASTROINTESTINAL CARCINOID-TUMORS
    HOUGH, DR
    CHAN, A
    DAVIDSON, H
    CANCER, 1983, 51 (12) : 2206 - 2208
12345